Loading…
Iodination of verapamil for a stronger induction of death, through GSH efflux, of cancer cells overexpressing MRP1
A series of iodinated derivatives of verapamil were synthesized and tested on cells overexpressing the MRP1 drug transporter in order to design novel anti-cancer compounds targeting and killing resistant cancer cells. The multidrug resistance protein 1 (MRP1), involved in multidrug resistance (MDR)...
Saved in:
Published in: | Bioorganic & medicinal chemistry 2010-09, Vol.18 (17), p.6265-6274 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A series of iodinated derivatives of verapamil were synthesized and tested on cells overexpressing the MRP1 drug transporter in order to design novel anti-cancer compounds targeting and killing resistant cancer cells.
The multidrug resistance protein 1 (MRP1), involved in multidrug resistance (MDR) of cancer cells, was found to be modulated by verapamil, through stimulation of GSH transport, leading to apoptosis of MRP1-overexpressing cells. In this study, various iodinated derivatives of verapamil were synthesized, including iodination on the B ring, known to be involved in verapamil cardiotoxicity, and assayed for the stimulation of GSH efflux by MRP1. The iodination, for nearly all compounds, led to a higher stimulation of GSH efflux. However, determination of concomitant cytotoxicity is also important for selecting the best compound, which was found to be 10-fold more potent than verapamil. This will then allow us to design original anti-cancer compounds which could specifically kill the resistant cancer cells. |
---|---|
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/j.bmc.2010.07.031 |